Skip to content
The Nexus
DossierENTITY

GLP-1 pill market

Coverage of GLP-1 pill market in the Nexus archive.

Earliest in view: Jun 7 · 23:35 UTCMost recent: Jun 7 · 23:35 UTC
Co-mentioned in this coverage
Wegovytopic1Foundayotopic1Eli Lillyorganization1
Recent coverage
  • HEALTHJun 7 · 23:35 UTCMARKETWATCH
    The Wegovy pill is still dominating the GLP-1 pill market

    The Wegovy pill continues to be a leading choice for weight loss in the GLP-1 pill market in the U.S., maintaining its dominance despite the introduction of Foundayo, Eli Lilly’s competing GLP-1 pill.